Osteopore Limited filed its Annual on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.078 AUD | +8.33% | -77.71% | -88.18% |
04-23 | Australian Shares Rise on Business Activity Growth; Osteopore Soars 127% | MT |
04-23 | Osteopore Commences In-Human Clinical Trials for Knee Preservation; Shares Surge 194% | MT |
1st Jan change | Capi. | |
---|---|---|
-88.18% | 5.18M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.84% | 40.7B | |
+24.51% | 32.25B | |
+3.43% | 26.53B | |
+15.25% | 25.02B |
- Stock Market
- Equities
- OSX Stock
- News Osteopore Limited
- Osteopore Limited Auditor Raises 'Going Concern' Doubt